New York Life Investments ETF Trust NYLIM U.S. Large Cap R&D Leaders ETF
LRND
2 hedge funds and large institutions have $4.77M invested in New York Life Investments ETF Trust NYLIM U.S. Large Cap R&D Leaders ETF in 2023 Q3 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.
0.02% less ownership
Funds ownership: 95.02% → 95% (-0.02%)
2% less capital invested
Capital invested by funds: $4.89M → $4.77M (-$113K)
33% less funds holding
Funds holding: 3 → 2 (-1)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AssetMark Inc
Concord,
California
|
-$771 |
LRND Hedge Fund Activity: Q3 2023 in Review
2 of the 6,312 institutional investors tracked by Wall St. Rank reported a position in New York Life Investments ETF Trust NYLIM U.S. Large Cap R&D Leaders ETF (LRND) for Q3 2023, worth a combined $4.77M — down 2.3% from $4.89M a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of LRND and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.
The largest seller was AssetMark Inc, exiting entirely with an estimated $771 sold.
- 2 institutional investors held New York Life Investments ETF Trust NYLIM U.S. Large Cap R&D Leaders ETF (LRND) as of Q3 2023, down from 3 in Q2 2023.
- Funds reported $4.77M of New York Life Investments ETF Trust NYLIM U.S. Large Cap R&D Leaders ETF stock for Q3 2023, down 2.3% quarter-over-quarter.
- 0 funds opened new New York Life Investments ETF Trust NYLIM U.S. Large Cap R&D Leaders ETF positions in Q3 2023 and 1 closed out, a net change of -1 holder.
- The largest New York Life Investments ETF Trust NYLIM U.S. Large Cap R&D Leaders ETF seller in Q3 2023 was AssetMark Inc, an estimated $771 sold.
Based on aggregated 13F filings for Q3 2023.